CC(Nc1nc(-c2cccc(Br)c2)cs1)c1nc2cc(Cl)c(N3CCCCC3)cc2n1CCOCCO
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?